Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | SCN1A | P35498 | 1/20 | 0.32 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.32 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16603263 | 0.91 | LMNA (0.32) | LMNACYP1A2CYP2D6SCN1ASCN2A | |
| SCHEMBL16603299 | 0.85 | NPC1 (0.33) | RAB9A | |
| SCHEMBL16603298 | 0.84 | MTNR1A (0.31) | MTNR1AMTNR1B | |
| SCHEMBL17518764 | 0.81 | MAPT (0.34) | LMNACYP1A2CYP2D6CYP3A4HPGD | |
| SCHEMBL16603136 | 0.80 | MTNR1A (0.35) | LMNAMTNR1AMTNR1BHPGDRAB9A | |
| SCHEMBL17759090 | 0.80 | MTNR1A (0.33) | MTNR1AMTNR1BRAB9A | |
| SCHEMBL16627960 | 0.79 | MAPT (0.33) | LMNAHPGD | |
| SCHEMBL17541750 | 0.79 | MAPT (0.33) | LMNAHPGDRAB9A | |
| SCHEMBL17518761 | 0.78 | MTNR1A (0.32) | LMNAMTNR1AMTNR1BHPGDRAB9A | |
| SCHEMBL16603169 | 0.76 | NPC1 (0.33) | RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170012223-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-01-12 | — | — | US | disclosed |
| US-20160260913-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-08 | — | — | US | disclosed |
| US-20160211469-A1 | ORGANIC LIGHT EMITTING MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-21 | — | — | US | disclosed |
| US-20160141522-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170012223-A1 | Organic Electroluminescent Materials and Devices | EML4, MT-ND4L, MT-ND4 | LMNA 2180/4885CYP1A2 585/4885CYP2D6 1524/4885 |
| US-20160141522-A1 | Organic Electroluminescent Materials and Devices | EED, ICOSLG, OCIAD1 | LMNA 4380/4885CYP1A2 1392/4885CYP2D6 2091/4885 |
| US-20160260913-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | EML4, TYR, L1CAM | LMNA 2703/4885CYP1A2 977/4885CYP2D6 1709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.